1.A Case of Right Atrial Thrombus and Left Pulmonary Embolus after the Bjork Procedure.
Masahisa Uematsu ; Masahiro Yamaguchi ; Hidetaka Ohashi ; Masanao Imai ; Yoshihiro Oshima ; Keiji Ataka ; Naoki Yoshimura
Japanese Journal of Cardiovascular Surgery 1996;25(5):329-332
A 5-year-old boy with tricuspid atresia who underwent the Björk procedure died due to right atrial thrombus and left pulmonary embolus 37 days after operation. It is suggested that thromboembolism may be a frequent complication after the Björk procedure due to the turbulent blood flow at the right atrio-ventricular anastomosis and also due to congestive blood flow. Anticoagulation therapy seems to be essential for postoperative management.
2.Clinical Evaluation of Delayed Sternal Closure following Open Heart Surgery in Neonates and Infants.
Masanao IMAI ; Masahiro YAMAGUCHI ; Hidetaka OHASHI ; Yoshihiro OSHIMA ; Naoki YOSHIMURA ; Tatsuro SATO ; Masahisa UEMATSU ; Yuhei HOSOKAWA ; Hideo TACHIBANA
Japanese Journal of Cardiovascular Surgery 1992;21(2):149-154
The cases of neonates and infants who underwent successful delayed sternal closure (DSC) using silastic rubber after open heart surgery were reviewed. The indication for DSC was cardiac dilatation with tamponade-like behavior upon attempted sternal closure in all. In 7 of 10 cases, DSC were possible within 4 days after operation. There were statistical decrease in heart rate (HR), left atrial pressure (LAP), cardiothoracic ratio (CTR) and inspiratory oxygen concentration of the respirator at the time of DSC compared to those in the early postoperative period. None of the patients had mediastinitis or other severe infection in the postoperative course. One patient each died of progressive pulmonary venous obstruction and of non-cardiac disease late postoperatively and 8 patients are long-term survivors. It is concluded that DSC is recommended whenever there is any hemodynamic deterioration due to attempted sternal closure following open heart surgery in infancy as it could be safely performed within 3 to 4 days after operation without any complication.
3.Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission.
Nobuhiko FUKUBA ; Shunji ISHIHARA ; Kousaku KAWASHIMA ; Yoshiyuki MISHIMA ; Naoki OSHIMA ; Yoshikazu KINOSHITA
Intestinal Research 2017;15(4):543-545
No abstract available.
Colitis, Ulcerative*
;
Humans
;
Recurrence*
;
Ulcer*
4.Small Intestinal Bacterial Overgrowth in Patients with Refractory Functional Gastrointestinal Disorders.
Shino SHIMURA ; Norihisa ISHIMURA ; Hironobu MIKAMI ; Eiko OKIMOTO ; Goichi UNO ; Yuji TAMAGAWA ; Masahito AIMI ; Naoki OSHIMA ; Shuichi SATO ; Shunji ISHIHARA ; Yoshikazu KINOSHITA
Journal of Neurogastroenterology and Motility 2016;22(1):60-68
BACKGROUND/AIMS: Small intestinal bacterial overgrowth (SIBO) is considered to be involved in the pathogenesis of functional gastrointestinal disorders (FGID). However, the prevalence and clinical conditions of SIBO in patients with FGID remain to be fully elucidated. Here, we examined the frequency of SIBO in patients with refractory FGID. METHODS: We prospectively enrolled patients with refractory FGID based on Rome III criteria. A glucose hydrogen breath test (GHBT) was performed using a gas analyzer after an overnight fast, with breath hydrogen concentration measured at baseline and every 15 minutes after administration of glucose for a total of 3 hours. A peak hydrogen value > or = 10 ppm above the basal value between 60 and 120 minutes after administration of glucose was diagnosed as SIBO. RESULTS: A total of 38 FGID patients, including 11 with functional dyspepsia (FD), 10 with irritable bowel syndrome (IBS), and 17 with overlapping with FD and IBS, were enrolled. Of those, 2 (5.3%) were diagnosed with SIBO (one patient diagnosed with FD; the other with overlapping FD and IBS). Their symptoms were clearly improved and breath hydrogen levels decreased to normal following levofloxacin administration for 7 days. CONCLUSIONS: Two patients initially diagnosed with FD and IBS were also diagnosed with SIBO as assessed by GHBT. Although the frequency of SIBO is low among patients with FGID, it may be important to be aware of SIBO as differential diagnosis when examining patients with refractory gastrointestinal symptoms, especially bloating, as a part of routine clinical care.
Adult
;
Blind Loop Syndrome
;
Breath Tests
;
Diagnosis, Differential
;
Dyspepsia
;
Gastrointestinal Diseases*
;
Glucose
;
Humans
;
Hydrogen
;
Irritable Bowel Syndrome
;
Levofloxacin
;
Prevalence
;
Prospective Studies